hsa-miR-410-3p appears to directly target STAT3, leading to a reduction of IL-10 in T cells of patients with systemic lupus erythematosus (94), and was also shown to be elevated in the plasma of these patients (95). This evidence concerns the gene STAT3 and systemic lupus erythematosus.